FindTrial
Sign In

Effect of ED-71 on the incident fractures in osteoporotic patients

Effect of ED-71 on the incident fractures in osteoporotic patients

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220020
Enrollment
Unknown
Registered
2005-09-01
Start date
2005-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

investigational material(s) Generic name etc : ED-71 INN of investigational material : Therapeutic category code : 311 Vitamin A, D and preparations Dosage and Administration for Investigational mate

Sponsors

Chugai Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Osteoporotic patients with at least one fragility fracture and/or those with low bone mineral density

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Incidence of vertebral fracture—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026